Douglas Roblin to Mineralocorticoid Receptor Antagonists
This is a "connection" page, showing publications Douglas Roblin has written about Mineralocorticoid Receptor Antagonists.
Connection Strength
0.113
-
Increasingly restrictive definitions of hyperkalemia outcomes in a database study: effect on incidence estimates. Pharmacoepidemiol Drug Saf. 2010 Jan; 19(1):19-25.
Score: 0.090
-
Diabetes and drug-associated hyperkalemia: effect of potassium monitoring. J Gen Intern Med. 2010 Apr; 25(4):326-33.
Score: 0.023